Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Exchange Rate Effect (2024 - 2025)

Silence Therapeutics (SLN) has disclosed Exchange Rate Effect for 2 consecutive years, with -$129000.0 as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect rose 18.87% to -$129000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $195000.0 through Dec 2025, up 225.0% year-over-year, with the annual reading at $195000.0 for FY2025, 225.0% up from the prior year.
  • Exchange Rate Effect hit -$129000.0 in Q4 2025 for Silence Therapeutics, down from -$106000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $268000.0 in Q3 2024 to a low of -$159000.0 in Q4 2024.